CPCRX:NASDAQ
Comstock Capital Value Fund Class I – CPCRX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 4.34 | 0.00 (0.00%) | 4.05 - 4.35 | 0.0 |
Market data as of 12:00AM 04/01/25. Quotes are delayed by at least 15 min.
Overview - CPCRX
The investment seeks to maximize total return, consisting of capital appreciation and current income.
The fund follows a value oriented strategy and seeks to achieve its investment objective by investing in equity and debt securities, money market instruments, and derivatives. It may invest in, and may shift frequently among, a wide range of asset classes and market sectors. The fund may invest up to 65% of its assets in equity and debt securities of foreign issuers, including those in emerging markets. It may invest without limit in high yield debt securities, but currently the advisor intends to limit such investments to 35% of its assets.
Growth of $10,000 (10 Years)
| Total Return | -8.78% |
|---|
| Yield (Trailing 12 Mo.) | 1.99% |
|---|
| Expense Ratio | 3.31% |
|---|
| Front Load | None |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $500,000 |
|---|
| Management Tenure | 3 Years |
|---|
| Fund Inception | 08/22/1995 |
|---|
Trailing Total Returns - CPCRX
as of 02/28/2025
| Timeframe | CPCRX | S&P 500 | Trading--Inverse Equity |
|---|
| 1 Month | 1.65% | -1.30% | -- |
|---|
| 3 Month | 2.05% | -0.97% | -- |
|---|
| Year-to-Date | 2.86% | 1.44% | -- |
|---|
| 1 Year | 8.32% | 18.41% | -- |
|---|
| 3 Year | 5.84% | 12.55% | -- |
|---|
| 5 Year | 3.24% | 16.85% | -- |
|---|
| 10 Year | -5.55% | 12.98% | -- |
|---|
| Since Inception | -8.78% | 11.12% | -- |
|---|
Sector Allocation - CPCRX
as of 02/28/2025
| Basic Materials | | 6.17% |
|---|
| Consumer Cyclical | | 7.29% |
|---|
| Financial Services | | 2.30% |
|---|
| Real Estate | | 1.78% |
|---|
| Consumer Defensive | | 8.70% |
|---|
| Healthcare | | 18.98% |
|---|
| Utilities | | 6.45% |
|---|
| Communication Services | | 10.89% |
|---|
| Energy | | 2.54% |
|---|
| Industrials | | 10.85% |
|---|
| Technology | | 24.05% |
|---|
Asset Allocation - CPCRX
as of 02/28/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | 0.00 | | | 85.81 | 85.81 |
|---|
| Bond | 0.00 | | | 0.00 | 0.00 |
|---|
| Other | 0.00 | | | 0.59 | 0.59 |
|---|
| Foreign Stock | 0.00 | | | 3.81 | 3.81 |
|---|
| Foreign Bond | 0.00 | | | 0.00 | 0.00 |
|---|
| Total | 0.00 | | | 90.21 | 90.21 |
|---|
| Cash | 0.76 | | | 8.31 | 7.55 |
|---|
| Total Net Assets | $7.58M |
|---|
| Total Stock Holdings | 92 |
|---|
| Total Bond Holdings | 0 |
|---|
Top Ten Holdings - CPCRX
as of 02/28/2025
| Company | YTD Return | % of Assets |
|---|
| HashiCorp Inc Ordinary Shares Class A | -- | 4.50% |
|---|
| K | -- | 4.46% |
|---|
| United States Treasury Bills 5.11585% | -- | 3.83% |
|---|
| Axonics Inc | -- | 3.63% |
|---|
| Stericycle Inc | -- | 3.63% |
|---|
| AMED | -- | 3.35% |
|---|
| R1 RCM Inc | -- | 3.05% |
|---|
| Catalent Inc | -- | 2.81% |
|---|
| JNPR | -- | 2.73% |
|---|
| X | -- | 2.72% |
|---|
Valuation & Growth - CPCRX
as of 02/28/2025
| Valuation | CPCRX | Category Range |
|---|
| Price/Earnings | 20.09 | |
|---|
| Price/Book | 1.99 | |
|---|
| Price/Sales | 1.17 | |
|---|
| Price/Cash Flow | 11.69 | |
|---|
| Dividend Yield | 0.97 | |
|---|
| LT Earnings | 12.88 | |
|---|
| Historical Earnings | | |
|---|
| Sales Growth | 3.28 | |
|---|
| Cash-Flow Growth | 0.1 | |
|---|
| Book-Value Growth | 4.93 | |
|---|
